Zai Lab (ZLAB) Return on Assets (2019 - 2026)

Zai Lab (ZLAB) posted Return on Assets of 0.0% for Q1 2026, down 4.3% sequentially from 0.0% in Q4 2025, and little changed YoY from 0.0% in Q1 2025.

Zai Lab (ZLAB) Return on Assets (2019 - 2026) Analysis & Trends

Zai Lab has reported Return on Assets for 7 years, with the latest figure at 0.0% in Q1 2026.

Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Assets eased to 0.0% in Q1 2026 per ZLAB's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Assets peaked at 0.0% in Q4 2025 and troughed at 0.0% in Q3 2022.
A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
The widest YoY moves for Return on Assets: up 0 bps in 2022, down 0 bps in 2022.
Over 5 years, Return on Assets stood at 0.0% in 2022, then grew by 9 bps to 0.0% in 2023, then rose by 26 bps to 0.0% in 2024, then soared by 36 bps to 0.0% in 2025, then retreated by 4 bps to 0.0% in 2026.
According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.00%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.01%
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.00%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	0.00%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.00%
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	0.00%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.00%
10	Zai Lab	2.91 Bn	2.20 Bn	58.15 Mn	0.00%

Download Data